0001981456-24-000001.txt : 20240624
0001981456-24-000001.hdr.sgml : 20240624
20240624082144
ACCESSION NUMBER: 0001981456-24-000001
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
ITEM INFORMATION: Investment Company Act Section 3(c)
ITEM INFORMATION: Section 3(c)(7)
FILED AS OF DATE: 20240624
DATE AS OF CHANGE: 20240624
EFFECTIVENESS DATE: 20240624
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: India Life Sciences Fund IV
CENTRAL INDEX KEY: 0001981456
ORGANIZATION NAME:
IRS NUMBER: 000000000
STATE OF INCORPORATION: K7
FISCAL YEAR END: 0331
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-485350
FILM NUMBER: 241062165
BUSINESS ADDRESS:
STREET 1: SIGNATURE BUILDING, 1505B, 15/F
STREET 2: BLOCK 13B, ZONE 1 GIFT SEZ
CITY: GANDHINAGAR, GUJARAT
STATE: K7
ZIP: 382355
BUSINESS PHONE: 91-402-354-1305
MAIL ADDRESS:
STREET 1: SIGNATURE BUILDING, 1505B, 15/F
STREET 2: BLOCK 13B, ZONE 1 GIFT SEZ
CITY: GANDHINAGAR, GUJARAT
STATE: K7
ZIP: 382355
D/A
1
primary_doc.xml
X0708
D/A
LIVE
0001981456
India Life Sciences Fund IV
SIGNATURE BUILDING, 1505B, 15/F
BLOCK 13B, ZONE 1 GIFT SEZ
GANDHINAGAR, GUJARAT
K7
INDIA
382355
91-402-354-1305
INDIA
None
None
Business Trust
true
2023
Hariharnath
Buggana
Signature Building, 1505A, 15/F
Block 13B, Zone 1 GIFT SEZ
Gandhinagar, Gujarat
K7
INDIA
382355
Executive Officer
Partner of the Fund Management Entity of the Issuer
Pooled Investment Fund
Private Equity Fund
false
Decline to Disclose
- 06b
- 3C
- 3C.7
true
0001981456-23-000001
2023-07-06
false
true
true
false
0
Lazard Asia Limited
None
None
None
1 Raffles Place 29-63, Tower 2
One Raffles Place Tower 2 City
Singapore
U0
SINGAPORE
048616
true
Lazard Freres & Co. LLC
2528
None
None
30 Rockefeller Plaza
New York
NY
NEW YORK
10020-5900
All States
false
Lazard & Co., Limited
None
None
None
50 Stratton Street
London
X0
UNITED KINGDOM
W1J 8LL
true
Lazard Freres SAS
None
None
None
175, Boulevard Haussmann
Paris
I0
FRANCE
75008
true
Indefinite
115640000
Indefinite
false
16
600000
0
0
true
Class B Unitholders are entitled to a performance allocation. Fund management entity and service provider are entitled to a management fee. The performance allocation and management fee are disclosed in the Issuer's confidential offering materials.
false
India Life Sciences Fund IV
Hariharnath Buggana
Hariharnath Buggana
Partner of the Fund Management Entity of the Issuer
2024-06-21